Advertisement
Free access | 10.1172/JCI109572
Department of Medicine, Moffitt Hospital, San Francisco, San Francisco, California 94143
Section of Rheumatology and Clinical Immunology, Moffitt Hospital, San Francisco, San Francisco, California 94143
Department of Dermatology, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94143
Find articles by Stobo, J. in: JCI | PubMed | Google Scholar
Department of Medicine, Moffitt Hospital, San Francisco, San Francisco, California 94143
Section of Rheumatology and Clinical Immunology, Moffitt Hospital, San Francisco, San Francisco, California 94143
Department of Dermatology, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94143
Find articles by Kennedy, M. in: JCI | PubMed | Google Scholar
Department of Medicine, Moffitt Hospital, San Francisco, San Francisco, California 94143
Section of Rheumatology and Clinical Immunology, Moffitt Hospital, San Francisco, San Francisco, California 94143
Department of Dermatology, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94143
Find articles by Goldyne, M. in: JCI | PubMed | Google Scholar
Published November 1, 1979 - More info
Prostaglandins (PG) of the E series, PGE1 and PGE2 (PGEs), can induce elevations of intracellular cyclic AMP (cAMP) among thymus-derived (T) lymphocytes (T cells) and inhibit their reactivity. For example, 0.1 μM of PGEs induces a two- to threefold increase of intracellular cAMP among human peripheral blood T cells and a 20-30% suppression of their blastogenic response to phytohemagglutinin. However, this suppression actually represents the net reactivity of T-cell populations demonstrating quite different responses to PGEs. Fractionation of T-enriched populations on a discontinuous density gradient yields a population of high density cells whose phytohemagglutinin-induced blastogenic response is suppressed 60%; a population of intermediate density cells whose response is suppressed 20%; and a population of low density T cells whose response is not suppressed, but is enhanced 20% by both of the PGEs. The diametrically opposite responses of low and high density T cells to the PGEs is not related to any difference in their intrinsic mitogen reactivity nor is it influenced by interactions with other T cells, bone marrow-derived (B) cells, or monocytes. Moreover, the distinct blastogenic response of low and high density T cells to PGEs does not simply correlate with PGE-mediated activation of adenylate cyclase. PGE2 induced comparable absolute and identical relative increases of intracellular cAMP among the low and high density T cells. Cholera toxin, a potent activator of adenylate cyclase, and exogenous 8-bromo cAMP mimicked the effects of the PGEs on these two T-cell populations. These data demonstrate that T cells are heterogeneous with regard to their response to the PGEs. Thus, PGEs should be considered as potential regulators rather than as universal suppressors for T-cell reactivity. Moreover, the effect of PGEs on the blastogenic response of a given T-cell population depends upon intracellular events which occur subsequent to elevations of cAMP.